Emily V. Nosova

Emily V. Nosova

Auto-generated profile, based on publicly available information

Emily V. Nosova

Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
GOGrenye O’Malley
Grenye O’Malley
DADushyanthy Arumugam
Dushyanthy Arumugam
SOSelassie Ogyaadu
Selassie Ogyaadu
CLCamilla Levister
Camilla Levister
ENEmily Nosova
Emily Nosova
CLCarol J. Levy
Carol J. Levy

3 March 2020 in Journal of Diabetes
Verified
Journal Article
Closed access
PDF file
ENEmily V. Nosova
Emily V. Nosova
GOGrenye O'MAlley
Grenye O'MAlley
EDEyal Dassau
Eyal Dassau
CLCarol J. Levy
Carol J. Levy

3 July 2021 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
PDF file
GOGrenye O’Malley
Grenye O’Malley
BRBarak Rosenn
Barak Rosenn
ENEmily V. Nosova
Emily V. Nosova
YKYogish C. Kudva
Yogish C. Kudva
SSSophia Scarpelli Shchur
Sophia Scarpelli Shchur
CLCarol J. Levy
Carol J. Levy

13 August 2022 in Case Reports in Endocrinology
Verified
Journal Article
Open access
PDF file
LSLeena Shah
Leena Shah
ENEmily V. Nosova
Emily V. Nosova
JBJoshua B. Bederson
Joshua B. Bederson
KCKhadeen Christi Cheesman
Khadeen Christi Cheesman
Background. Cushings disease (CD) recurrence in pregnancy is thought to be associated with estradiol fluctuations during gestation. CD recurrence in the immediate postpartum period in a patient with a documented dormant disease during pregnancy has never been reported. Case Report. A 30-year-old woman with CD had improvement of her symptoms after transsphenoidal resection (TSA) of her pituitary lesion. She conceived unexpectedly 3 months postsurgery and had no symptoms or biochemical evidence of recurrence during pregnancy. After delivering a healthy boy, she developed CD 4 weeks postpartum and underwent a repeat TSA. Despite repeat TSA, she continued to have elevated cortisol levels that were not well controlled with medical management. She eventually had a bilateral adrenalectomy. Discussion. CD recurrence may be higher in the peripartum period, but the link between pregnancy and CD recurrence and/or persistence is not well studied. Potential mechanisms of CD recurrence in the postpartum period are discussed below. Conclusion. We describe the first report of recurrent CD that was quiescent during pregnancy and diagnosed in the immediate postpartum period. Understanding the risk and mechanisms of CD recurrence in pregnancy allows us to counsel these otherwise healthy, reproductive-age women in the context of additional family planning.